Modified · Net Portfolio Divestitures

In the fourth quarter of 2025, the Company took various actions as a result of a strategic review of its assets and businesses aimed at advancing and scaling its core operations, including the value-based care business at Optum Health. InFor the first quarter of three and six months ended June 30, 2026, these actions resulted in a net loss of $39 million and a net gain of $230191 million reflecting gains , respectively. For the three and six months ended June 30, 2026, net portfolio divestitures included incremental losses on businesses held for sale, while the year-to-date results also included a net gain on the sales of businesses previously held for sale as of December 31, 2025. By segment, partially offset by incremental second quarter impacts consisted of net losses on other businesses held for sale. By segmentof $35 million and $4 million at Optum Health and Optum Insight, this included respectively. Year-to-date impacts consisted of gains of $528524 million and $8 million at Optum Insight and Optum Rx, respectively, partially offset by a net loss of $306341 million at Optum Health. Gains and losses on portfolio actions were recorded within operating costs on the Condensed Consolidated Statements of Operations.